Xinhui Liao

Shenzhen, 518000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Translational reprogramming of TGF-β signaling via TRMT61A-mediated tRNA m1A drives prostatic fibrosis and hyperplasia.

Translational reprogramming of TGF-β signaling via TRMT61A-mediated tRNA m1A drives prostatic fibrosis and hyperplasia.

Journal: Cellular signalling

Published: April 07, 2026

Correction: CCDC137 knockdown suppresses bladder cancer progression by downregulating SCD.

Correction: CCDC137 knockdown suppresses bladder cancer progression by downregulating SCD.

Journal: Journal of translational medicine

Published: November 04, 2025

Mediator complex subunit 8 promotes bladder cancer progression via Stearoyl-CoA desaturase.

Mediator complex subunit 8 promotes bladder cancer progression via Stearoyl-CoA desaturase.

Journal: Cellular and molecular life sciences : CMLS

Published: September 24, 2025

Outcomes of robotic prostatectomy with lymph node removal and early hormone therapy for locally advanced prostate cancer (pT3-4N0-1M0).

Outcomes of robotic prostatectomy with lymph node removal and early hormone therapy for locally advanced prostate cancer (pT3-4N0-1M0).

Journal: BMC urology

Published: May 10, 2025

Integrating machine learning and Mendelian randomization for identifying genetic biomarkers in bladder cancer: implications for early diagnosis and targeted therapies.

Integrating machine learning and Mendelian randomization for identifying genetic biomarkers in bladder cancer: implications for early diagnosis and targeted therapies.

Journal: International journal of surgery (London, England)

Published: April 30, 2025

CCDC137 knockdown suppresses bladder cancer progression by downregulating SCD.

CCDC137 knockdown suppresses bladder cancer progression by downregulating SCD.

Journal: Journal of translational medicine

Published: April 02, 2025

Extraperitoneal laparoscopic versus transperitoneal robot-assisted laparoscopic approaches during radical prostatectomy for low-risk or intermediate-risk prostate cancer.

Extraperitoneal laparoscopic versus transperitoneal robot-assisted laparoscopic approaches during radical prostatectomy for low-risk or intermediate-risk prostate cancer.

Journal: Translational andrology and urology

Published: December 21, 2024

Retraction notice to "High expression of enhancer RNA MARC1 or its activation by DHT is associated with the malignant behavior in bladder cancer" [Exp. Cell Res. Volume 370, Issue 2, 15 September 2018, Pages 303-311].

Retraction notice to "High expression of enhancer RNA MARC1 or its activation by DHT is associated with the malignant behavior in bladder cancer" [Exp. Cell Res. Volume 370, Issue 2, 15 September 2018, Pages 303-311].

Journal: Experimental cell research

Published: August 31, 2024

Identification and preliminary analysis of hub genes associated with bladder cancer progression by comprehensive bioinformatics analysis.

Identification and preliminary analysis of hub genes associated with bladder cancer progression by comprehensive bioinformatics analysis.

Journal: Scientific reports

Published: April 20, 2023

Hypertension Promotes the Proliferation and Migration of ccRCC Cells by Downregulation of TIMP3 in Tumor Endothelial Cells through the miR-21-5p/TGFBR2/P38/EGR1 Axis.

Hypertension Promotes the Proliferation and Migration of ccRCC Cells by Downregulation of TIMP3 in Tumor Endothelial Cells through the miR-21-5p/TGFBR2/P38/EGR1 Axis.

Journal: Molecular cancer research : MCR

Published: March 02, 2022

Single-cell landscape reveals active cell subtypes and their interaction in the tumor microenvironment of gastric cancer.

Single-cell landscape reveals active cell subtypes and their interaction in the tumor microenvironment of gastric cancer.

Journal: Theranostics

Published: February 08, 2022

A synthetic targeted RNA demethylation system based on CRISPR-Cas13b inhibits bladder cancer progression.

A synthetic targeted RNA demethylation system based on CRISPR-Cas13b inhibits bladder cancer progression.

Journal: Clinical and translational medicine

Published: September 26, 2021

Showing 1-12 of 31

Last Updated: 09/26/2026